Ken Griffin
ONCO icon

Ken Griffin’s Onconetix ONCO Stock Holding History

Ken Griffin’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-313
Closed -$48.6K – 13677
2025
Q3 		$48.6K Buy
+313
New +$52.7K ﹤0.01% 12225
2024
Q1 		– Hold
0
– -$9.95K – 15233
2023
Q4 		– Hold
0
– – – 13128
2022
Q4 		– Hold
0
– -$24K – 15282
2022
Q3 		– Hold
0
– – – 12007
2022
Q2 		– Hold
0
– -$417K – 13743
2022
Q1 		– Hold
0
– – – 9805

Other funds holding ONCO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Ken Griffin's ONCO Position: Q4 2025 in Review

Ken Griffin sold out of Onconetix (ONCO) in Q4 2025, closing a stake of 313 shares — an estimated $48.6K sold.

Ken Griffin first reported a position in ONCO in Q3 2025 and held it in 1 quarter. The position peaked at $48.6K in Q3 2025. 5 funds tracked by Wall St. Rank hold ONCO as of Q4 2025.

  • Ken Griffin reported no remaining Onconetix position as of Q4 2025 after selling out during the quarter.
  • Ken Griffin sold 313 Onconetix shares in Q4 2025, an estimated $48.6K.
  • Ken Griffin first reported a position in Onconetix in Q3 2025 and held it in 1 quarter.
  • Ken Griffin's Onconetix position peaked at $48.6K in Q3 2025.
  • 5 funds tracked by Wall St. Rank held Onconetix as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.